| 501 | GUIDI, JOSEPHSCOTCH PLAINS, NJ · 07076 | DRUG DEVELOPMENT · GSK | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-10-12 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014FEC filing ↗ |
| 502 | GRADY, CLEVELANDPHILADELPHIA, PA · 19104 | PRICING/REIMBURSEMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 503 | SPIES, CHRISTINA MARIEDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 504 | LONG, CYNTHIA M.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 505 | GLAUNERT, KEVIN J.DURHAM, NC · 27709 | SR. SPECIALTY ACCOUNT SPECIALIST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 506 | RIVERA, VICENTE S.DURHAM, NC · 27709 | SR. VACCINE ACCT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 507 | TURNER, TALBERTDURHAM, NC · 27709 | DISTRICT SALES MGR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 508 | KARSAY, STEPHANIEDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 509 | BOKER, ROBERT A.DURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 510 | LAMB, MICHAEL K.DURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 511 | WOLFF, KEITH M.DURHAM, NC · 27709 | SR. SPECIALTY ACCOUNT SPECIALIST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 512 | BARGO, JEFFREY REEDDURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 513 | HARRIS, GERI ADURHAM, NC · 27701 | EXECUTIVE DIRECTOR, TRANSFORMATION, ST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 514 | MCCANN, EMILY SUZANNEDURHAM, NC · 27709 | SR ACCT SPEC, VIIV · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 515 | DELK, DEBBIE TAYLORDURHAM, NC · 27709 | VACCINE KEY ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-06 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 516 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXO SMITH KLINE | WARNOCK FOR GEORGIAC00736876 | 2025-10-04 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943738FEC filing ↗ |
| 517 | MATTHEWS, BRYANCHAPEL HILL, NC · 27514 | PHARMACEUTICALS · GSK | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-10-04 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1940014FEC filing ↗ |
| 518 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | FETTERMAN FOR PAC00765800 | 2025-02-27 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1887330FEC filing ↗ |
| 519 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | MARK KELLY FOR SENATEC00696526 | 2025-02-15 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1887093FEC filing ↗ |
| 520 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | WARNOCK FOR GEORGIAC00736876 | 2025-02-04 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1887818FEC filing ↗ |